
Liquid biopsy firm Thrive launches with $110M Series A round
The company has a 10,000-patient prospective trial with Geisinger fully enrolled to test CancerSEEK, a test developed at Johns Hopkins University.
The company has a 10,000-patient prospective trial with Geisinger fully enrolled to test CancerSEEK, a test developed at Johns Hopkins University.
Oncology Analytics' aims to improve affordability is a clear reason why an insurer like BlueCross BlueShield is investing in the startup - as cancer drug costs skyrocket, payers are looking for ways to mitigate the disease's impact on their bottom line.
Investors may have pumped 45 percent more money into digital health companies in 2012 than they did in 2011, but new data shows most of them are either still apprehensive or haven’t yet found the kind of deals they’re looking for. Rock Health’s year-in-review report on digital health investing delivers insights about investors’ interests in […]
Despite having their model overhauled in recent years, private health insurance providers appear to be earning healthy profits these days. In light of the overhaul, they also seem to have turned their focus toward consumers with new apps, cost transparency tools and wellness and fitness incentives. This has opened up doors for many startups, who […]
Initiate's strength is gathering data across multiple systems. The new Initiate Payer Data Management product hopes to cut administrative costs for insurance companies and other payers by gathering all patient information for every medical transaction.